Search Results
Results found for "Tack Kuntz"
- đ° GPCR Weekly News, June 5 to 11, 2023
Our website is updated as we confirm speakers so please check back often.
- đ° GPCR Weekly News, February 13 to 19, 2023
From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction.
- đ° GPCR Weekly News, September 18 to 24, 2023
If you couldn't make it, no sweat â our premium members can always go back and watch the recorded talks Short talk selections will be announced soon. Abstract submissions close on October 2nd.
- đ° GPCR Weekly News, February 26 to March 3, 2024
a resounding success; we have a waitlist for those eager to attend this course, which wil be coming back
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Welcome back GPCR fans, The pace of GPCR innovation is accelerating at a rate that can be difficult to
- đ° GPCR Weekly News, August 28 to September 3, 2023
You can submit your poster abstracts using this form and short talks will be selected from abstracts. pathophysiology and treatment of CNS disorders GPCRs in Oncology and Immunology From outside to inside and back
- How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology
a cold email from a biologist heâd never met, asking if he could synthesize a molecule âwhen youâre back
- đ¤ŻMind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⌿ Nov 18 - 24, 2024
platform to connect from anywhere in the world And if you go for a Premium Membership , you'll not only back
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Additionally, DMS is not universally applicable to all proteins; it struggles with proteins that lack
- Allosteric Binding Data Interpretation in Complex Receptor Systems
Cooperativity Tracks Species Movement Allosteric models quantify ligand effects through cooperativity Classical affinity models cannot capture these interactions because they lack the dimensionality required
- đ° Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors Industry News Sosei Heptares to take back In Parkinsonâs Treatment GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- đ° GPCR Weekly News, November 20 to 26, 2023
with Multispan Cell Engineering and Assay Services $3bn sales potential for drug Sosei Heptares wants back Discovery and Development GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
It is the lack of alignment between intellectual property and business intent. 2ď¸âŁ Ownership and control
- Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls
Unexpected outcomes typically trace back to a single issue: transferring assumptions from idealized models Curve shifts track site properties, not system stoichiometry. Dr.
- The Hidden Burn: How Internal Misalignment Drains Your Biotechâs Runway
You track the burn rate. You watch the runway shrink. You delay hires. Weâre not talking about personality clashes or investor drama. đ Weâre talking about the type of quiet This breeds passive execution, second-guessing, and a lack of ownership .
- From Failed Experiments to Predictive GPCR Models
His lab has already begun using AlphaFold models to identify ligands for targets that lack experimental
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
In every lab, candidates fail not because they lack potency at a receptor, but because they stumble at
- âľSailing the GPCR Seas: Your Weekly Research Voyage! ⌿ Nov 11 - 17, 2024
GPCR University đĽ Access to the recorded classes of GPCR Courses and talks from Symposia đ˛ Discounted with AEF0217 in young adults with Down syndrome Novartis pays SchrĂśdinger $150M, bets billions on the back
- The Moment Biotech Founders Realize the Money Is Gone
They track burn rate, but not decision reversibility. By the time concern turns into action, financial control has already weakened. đ The issue is not a lack The solution starts with recognizing that financial control is not about tracking money , but about maintaining They manage cash flow, but they do not actively track which strategic decisions can still be changed
- Structural landscape of the Chemokine Receptor system
CKRs can be classified into typical CKRs, atypical CKRs (ACKRs) which lack G-protein signaling, and viral variants of CCL15, namely CCL15L (residues 26-92) and CCL15M (residues 27-92), while the third structure lacks
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⌿ Nov 24 - Dec 1, 2024
We're zooming back to the future of GPCR discoveries. We're about to reveal our University CheatSheet âa sneaky peek at all our talks, presentations, and courses
- How Early Strategic Decision Making Creates Alignment and Better Results
đ Most founders look back at the end of the year and try to make sense of the results.
- Early Stage Biotech Hiring: What Really Holds a Team Together When the Science Starts to Drift
Not because they lack intelligence or motivation, but because they were hired for clarity, not for uncertainty Survival traits reveal themselves in how people talk about uncertainty, ownership, and unfinished work biotech environments. 1ď¸âŁ How candidates describe moments without clear answers: Listen to how they talk
- đ° GPCR Weekly News
We're excited to be back and share our weekly newsletter! Tracking N- and C-termini of C. elegans polycystin-1 reveals their distinct targeting requirements and
- Why Fundraising Mistakes Kill Strong Biotech Startups
This is where most biotech startup fundraising mistakes are born, not from lack of intelligence or discipline
- Artificial intelligence â faster, smarter, cheaper GPCR drug discovery
models, such as deep learning neural networks, are often referred to as "black boxes" because they lack databases from experimental labs and new AI techniques will allow more associations and will promote multi-task
- Decoding β-Arrestins: from Structure to function
Despite their contributions, these methods often lack cellular auxiliary structures and proteins.
















